FDA seeks comments on new draft guidance clarifying good reprint practices
In a 3 March 2014 Federal Register notice, the US Food and Drug Administration (FDA) distributed a revised draft guidance document titled ‘Distributing Scientific and Medical Publications on Unapproved New Uses — Recommended Practices’ for comment. The draft guidance, when finalised, is intended to replace FDA’s January 2009 final guidance titled ‘Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices’. While the draft guidance is largely consistent with the 2009 guidance, restating and providing additional details that build on the existing criteria for the distribution of journal articles describing unapproved uses of drugs and medical devices, it does include new requirements for the dissemination of medical or scientific reference texts and clinical practice guidelines (CPGs), neither of which are explicitly discussed in the 2009 guidance.
The most notable difference between the draft guidance and the 2009 guidance is the introduction of a new category of publications, i.e. CPGs, that can fall within the ‘safe harbour’ for distribution of publications that discuss unapproved uses of drugs and devices. To fall within the scope of the draft guidance, CPGs must meet the Institute of Medicine’s standards for CPG ‘tustworthiness’…
Click on the link below to read the rest of the Hogan Lovells briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Hogan Lovells
News from The Lawyer
Briefings from Hogan Lovells
The decision of the US Court of Appeals has raised questions about how issuers should present their disclosures on conflict minerals under Exchange Act Rule 13p-1 and Form SD.
An interesting judgment was delivered by the Honourable J Majiki on 19 November 2013 in the Eastern Cape High Court, Port Elizabeth.
Analysis from The Lawyer
As international firms question their future in these small, closely linked markets, local lawyers too are eyeing the business environment with caution
Beyond the headline infrastructure projects, UK construction work is still recovering from the clobbering it took during the slump